Kindly provide List of antibiotics most preferable used in specific system wise disease ..
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching the Web
system wise antibiotic of choice table respiratory GI urinary CNS skin 2024 guidelines
I now have excellent data from medical textbooks and current guidelines. Let me compile the comprehensive system-wise antibiotic reference.
System-Wise Antibiotic Reference Guide
A comprehensive list of preferred antibiotics organized by organ system and clinical condition, based on current guidelines and standard pharmacology texts.
1. RESPIRATORY SYSTEM
Upper Respiratory Tract
| Condition | First-Line Antibiotic | Alternatives |
|---|---|---|
| Strep Pharyngitis | Amoxicillin 500 mg TID x 10 days | Penicillin V, Azithromycin (PCN allergy) |
| Acute Otitis Media | Amoxicillin 80-90 mg/kg/day | Amoxicillin-clavulanate (treatment failure) |
| Acute Sinusitis (bacterial) | Amoxicillin-clavulanate | Doxycycline, Levofloxacin |
| Pertussis (Whooping cough) | Azithromycin x 5 days | Clarithromycin, TMP-SMX |
| Epiglottitis | Ceftriaxone IV | Ampicillin-sulbactam |
Lower Respiratory Tract
| Condition | First-Line | Alternative |
|---|---|---|
| CAP - Outpatient, no comorbidities | Amoxicillin 1g TID OR Doxycycline 100 mg BID | Azithromycin (low resistance areas) |
| CAP - Outpatient, with comorbidities | Amoxicillin-clavulanate + Azithromycin | Respiratory fluoroquinolone (Levofloxacin/Moxifloxacin) |
| CAP - Inpatient | Beta-lactam + Macrolide (Azithromycin) | Respiratory fluoroquinolone monotherapy |
| CAP - ICU/Severe | Beta-lactam (Ceftriaxone/Piperacillin-tazobactam) + Azithromycin | Beta-lactam + Fluoroquinolone |
| Hospital-Acquired Pneumonia (HAP) | Piperacillin-tazobactam OR Cefepime + Vancomycin | Carbapenem if MDR suspected |
| Ventilator-Associated Pneumonia (VAP) | Broad-spectrum beta-lactam + cover MRSA (Vancomycin/Linezolid) | Guided by local antibiogram |
| COPD Exacerbation (bacterial) | Amoxicillin OR Doxycycline x 5-7 days | Amoxicillin-clavulanate |
| Pseudomonas risk (bronchiectasis, COPD) | Ciprofloxacin (oral); Anti-pseudomonal beta-lactam (IV) | Piperacillin-tazobactam + Aminoglycoside |
| Lung abscess | Amoxicillin-clavulanate | Clindamycin + Metronidazole |
| TB (Pulmonary) | HRZE (Isoniazid + Rifampicin + Pyrazinamide + Ethambutol) x 2 months, then HR x 4 months | Per DST results |
2. CARDIOVASCULAR SYSTEM
| Condition | Preferred Antibiotic | Notes |
|---|---|---|
| Infective Endocarditis - Streptococcal (sensitive) | Penicillin G or Ceftriaxone IV x 4 weeks | Add Gentamicin for 2 weeks in selected cases |
| IE - Staphylococcal (MSSA) | Nafcillin / Flucloxacillin IV x 4-6 weeks | Cloxacillin in some regions |
| IE - Staphylococcal (MRSA) | Vancomycin IV x 4-6 weeks | Daptomycin as alternative |
| IE - Enterococcal | Ampicillin + Gentamicin | Vancomycin + Gentamicin (Ampicillin-resistant) |
| Rheumatic fever prophylaxis | Benzathine Penicillin G IM monthly | Oral Penicillin V daily if IM not feasible |
| Pericarditis (bacterial) | Ceftriaxone IV | Based on organism when identified |
| IE Prophylaxis (high-risk dental) | Amoxicillin 2g PO (single dose, 30-60 min before) | Clindamycin if PCN allergic |
3. CENTRAL NERVOUS SYSTEM (CNS)
| Condition | First-Line Empiric | Notes |
|---|---|---|
| Bacterial Meningitis - Community-acquired | Ceftriaxone IV + Vancomycin | Add Ampicillin if age >50 years (Listeria cover) |
| Bacterial Meningitis - Neonatal | Ampicillin + Cefotaxime OR Aminoglycoside | Cover GBS, E. coli, Listeria |
| Meningococcal Meningitis | Penicillin G IV (once confirmed) | Ceftriaxone as empiric; prehospital benzylpenicillin |
| Pneumococcal Meningitis | Ceftriaxone + Vancomycin + Dexamethasone | Moxifloxacin if resistant |
| Brain Abscess | Metronidazole + Ceftriaxone | Add Vancomycin if post-neurosurgical/trauma |
| Cerebral Malaria (prophylaxis note) | (Antiprotozoal - Quinine/Artemisinins, not true antibiotics) | Doxycycline added in some regimens |
| Lyme Neuroborreliosis | Ceftriaxone IV x 14-21 days | Doxycycline (early/mild) |
| Neurosyphilis | Penicillin G IV x 10-14 days | Ceftriaxone IV alternative |
| Nosocomial/Post-surgical meningitis | Vancomycin + Cefepime or Meropenem | Cover Gram-negatives including Pseudomonas |
4. GASTROINTESTINAL SYSTEM
| Condition | First-Line Antibiotic | Notes |
|---|---|---|
| H. pylori (Triple therapy) | Amoxicillin + Clarithromycin + PPI x 14 days | Bismuth quadruple if high resistance area |
| H. pylori (Quadruple therapy) | Bismuth + Metronidazole + Tetracycline + PPI | Second-line or high clarithromycin resistance |
| Typhoid Fever | Ceftriaxone IV OR Azithromycin (oral, uncomplicated) | Ciprofloxacin (if susceptible) |
| Cholera | Doxycycline (single dose, adults) | Azithromycin, TMP-SMX |
| Traveler's Diarrhea (bacterial) | Azithromycin 500 mg OD x 3 days | Rifaximin (non-invasive E. coli) |
| C. difficile infection (mild-moderate) | Vancomycin oral OR Fidaxomicin | Metronidazole only if V/F unavailable |
| C. difficile (severe) | Vancomycin oral + Metronidazole IV | Fidaxomicin preferred for recurrence |
| Spontaneous Bacterial Peritonitis (SBP) | Cefotaxime IV OR Ceftriaxone | Ciprofloxacin oral (prophylaxis) |
| Peritonitis / Intra-abdominal infection | Piperacillin-tazobactam | Carbapenem if severe/MDR |
| Cholecystitis/Cholangitis (mild) | Cefazolin | Amoxicillin-clavulanate |
| Cholangitis (moderate-severe) | Piperacillin-tazobactam OR Ceftriaxone + Metronidazole | Carbapenem (MDR) |
| Shigellosis (dysentery) | Azithromycin (children); Ciprofloxacin (adults) | Ceftriaxone IV (severe) |
| Salmonellosis (invasive) | Ceftriaxone IV OR Ciprofloxacin | Azithromycin (resistant strains) |
5. URINARY TRACT (GENITOURINARY SYSTEM)
| Condition | First-Line | Notes |
|---|---|---|
| Uncomplicated UTI / Cystitis (female) | Nitrofurantoin x 5 days OR TMP-SMX x 3 days | Fosfomycin 3g single dose |
| Uncomplicated UTI (first-line alternatives) | Cefalexin x 7 days | Use local susceptibility patterns |
| UTI in pregnancy | Cefalexin OR Amoxicillin-clavulanate | Nitrofurantoin (avoid near term) |
| Acute Pyelonephritis (outpatient) | Ciprofloxacin x 7 days OR TMP-SMX x 14 days | Levofloxacin |
| Pyelonephritis (inpatient) | Ceftriaxone IV 1g Q24H | Piperacillin-tazobactam if severe |
| Complicated UTI | Based on culture; empiric Ceftriaxone or Ciprofloxacin | Adjust per sensitivity |
| CAUTI (catheter-associated UTI) | Remove/change catheter first; culture-directed therapy | Empiric Ceftriaxone or Pip-tazo |
| Prostatitis (acute bacterial) | Ciprofloxacin x 4 weeks (outpatient) | TMP-SMX, Levofloxacin |
| Gonorrhea (uncomplicated) | Ceftriaxone 500 mg IM single dose | No longer dual therapy in most guidelines |
| Chlamydia | Doxycycline 100 mg BID x 7 days | Azithromycin 1g single dose |
| Syphilis (primary/secondary) | Benzathine Penicillin G 2.4MU IM single dose | Doxycycline x 14 days (PCN allergy) |
| Bacterial vaginosis | Metronidazole 400-500 mg BID x 7 days | Clindamycin cream/oral |
| Pelvic Inflammatory Disease (PID) | Ceftriaxone IM + Doxycycline + Metronidazole | IV: Cefotetan or Cefoxitin + Doxycycline |
6. SKIN AND SOFT TISSUE
| Condition | First-Line | Notes |
|---|---|---|
| Impetigo (non-bullous) | Mupirocin topical | Cefalexin or Amoxicillin-clavulanate (extensive) |
| Impetigo (bullous/extensive) | Cefalexin OR Cloxacillin x 5-7 days | TMP-SMX if MRSA suspected |
| Cellulitis (non-purulent) | Cefalexin (mild/outpatient) | IV Cefazolin (moderate); Penicillin if Streptococcal |
| Cellulitis (MRSA risk) | TMP-SMX OR Doxycycline (outpatient) | Vancomycin IV (severe) |
| Furuncle/Carbuncle | Incision & drainage (primary); TMP-SMX if antibiotic needed | Clindamycin |
| Necrotizing Fasciitis (Type I - polymicrobial) | Surgical debridement + Piperacillin-tazobactam + Vancomycin | Carbapenem + Clindamycin (toxin suppression) |
| Necrotizing Fasciitis (Type II - Group A Strep) | Penicillin G + Clindamycin (toxin inhibition) | Broad-spectrum empiric until confirmed |
| Diabetic Foot Infection (mild) | Amoxicillin-clavulanate | Cefalexin if Streptococcal only |
| Diabetic Foot Infection (moderate-severe) | Piperacillin-tazobactam +/- Vancomycin | Ertapenem (outpatient parenteral) |
| Erysipelas | Penicillin V (oral) or Penicillin G (IV) | Cefalexin, Amoxicillin |
7. MUSCULOSKELETAL SYSTEM
| Condition | First-Line | Notes |
|---|---|---|
| Septic Arthritis (empiric) | Flucloxacillin/Nafcillin IV (Staph dominant) | Add Ceftriaxone for gonococcal |
| Septic Arthritis - MRSA | Vancomycin IV | Daptomycin alternative |
| Osteomyelitis (hematogenous, acute) | Flucloxacillin/Nafcillin IV x 4-6 weeks | Cefalexin (oral step-down) |
| Osteomyelitis (MRSA) | Vancomycin IV OR TMP-SMX + Rifampicin (oral) | Linezolid |
| Prosthetic joint infection | Based on organism; Vancomycin (empiric) + Rifampicin (biofilm) | Long course + often surgical intervention |
| Lyme arthritis | Doxycycline 100 mg BID x 28 days | Amoxicillin, Ceftriaxone IV |
8. ENT (EAR, NOSE, THROAT)
| Condition | First-Line | Notes |
|---|---|---|
| Acute Otitis Media | Amoxicillin 80-90 mg/kg/day x 5-10 days | Amoxicillin-clavulanate (treatment failure, age <2) |
| Otitis Externa | Ciprofloxacin + hydrocortisone ear drops | Topical Acetic acid |
| Malignant Otitis Externa | Ciprofloxacin IV + Topical | Piperacillin-tazobactam (Pseudomonas) |
| Acute Bacterial Sinusitis | Amoxicillin-clavulanate x 5-7 days | Doxycycline, Levofloxacin |
| Strep Throat / Tonsillitis | Amoxicillin x 10 days | Phenoxymethylpenicillin; Azithromycin (allergy) |
| Peritonsillar Abscess | Amoxicillin-clavulanate + drainage | Clindamycin |
| Ludwig's Angina | Ampicillin-sulbactam IV | Clindamycin + Metronidazole (PCN allergy) |
9. EYE (OPHTHALMOLOGY)
| Condition | First-Line | Notes |
|---|---|---|
| Bacterial Conjunctivitis | Chloramphenicol eye drops OR Tobramycin | Azithromycin eye drops |
| Gonococcal Conjunctivitis (adult) | Ceftriaxone IM single dose + topical | Eye irrigation essential |
| Neonatal Conjunctivitis (gonococcal) | Ceftriaxone IV/IM | Topical prophylaxis at birth |
| Neonatal Conjunctivitis (Chlamydia) | Azithromycin oral (systemic) | Erythromycin eye ointment |
| Corneal Ulcer (bacterial) | Fluoroquinolone eye drops (Ciprofloxacin/Moxifloxacin) | Fortified topical antibiotics |
| Orbital Cellulitis | Ceftriaxone IV +/- Metronidazole | Vancomycin if MRSA risk |
| Endophthalmitis | Intravitreal Vancomycin + Ceftazidime | IV antibiotics for severe cases |
10. BLOOD AND SYSTEMIC INFECTIONS
| Condition | First-Line Empiric | Notes |
|---|---|---|
| Sepsis (community-acquired) | Ceftriaxone + Metronidazole | Escalate based on source/culture |
| Sepsis (hospital-acquired) | Piperacillin-tazobactam + Vancomycin | Carbapenem if MDR risk |
| Bacteremia - Staph aureus (MSSA) | Nafcillin / Flucloxacillin IV | Never use oral for bacteremia |
| Bacteremia - MRSA | Vancomycin IV | Daptomycin (non-pulmonary) |
| Neutropenic fever (low-risk) | Ciprofloxacin + Amoxicillin-clavulanate (oral) | Monotherapy Levofloxacin |
| Neutropenic fever (high-risk) | Piperacillin-tazobactam IV (or Cefepime/Meropenem) | Add Vancomycin if catheter/mucositis |
| Typhus / Rickettsial disease | Doxycycline 100 mg BID x 7-14 days | Drug of choice regardless of age |
| Brucellosis | Doxycycline + Rifampicin x 6 weeks | Doxycycline + Gentamicin (severe) |
| Leptospirosis (mild) | Doxycycline 100 mg BID x 7 days | Amoxicillin |
| Leptospirosis (severe/Weil's disease) | Penicillin G IV OR Ceftriaxone IV |
Quick Reference Summary Table
| System | Most Common Bug | Antibiotic of Choice |
|---|---|---|
| Respiratory (CAP) | S. pneumoniae, Atypicals | Amoxicillin OR Doxycycline |
| Respiratory (HAP/VAP) | Pseudomonas, MRSA | Pip-tazo/Cefepime + Vancomycin |
| CNS (meningitis) | S. pneumoniae, N. meningitidis | Ceftriaxone + Vancomycin |
| Cardiovascular (IE) | Staph, Strep, Enterococcus | Penicillin / Vancomycin / Ampicillin-Gentamicin |
| GI (typhoid) | S. typhi | Ceftriaxone IV / Azithromycin |
| GI (C. diff) | C. difficile | Vancomycin oral / Fidaxomicin |
| Urinary | E. coli | Nitrofurantoin / TMP-SMX / Cefalexin |
| Skin/Soft tissue | Staph, Strep | Cefalexin / Flucloxacillin; Vancomycin (MRSA) |
| Bone/Joint | S. aureus | Flucloxacillin IV; Vancomycin (MRSA) |
| ENT | S. pneumoniae, H. influenzae | Amoxicillin / Amoxicillin-clavulanate |
| Eye | Staph, Pseudomonas | Topical fluoroquinolone / Chloramphenicol |
| Systemic/Sepsis | Polymicrobial | Pip-tazo ± Vancomycin (empiric) |
Key Principles:
- Always obtain cultures before starting antibiotics when feasible - de-escalate based on sensitivities
- Local antibiograms should guide empiric choices - resistance patterns vary by region
- MRSA coverage (Vancomycin/Linezolid/Daptomycin) should be added when risk factors are present
- Penicillin allergy assessment is essential - most patients labeled "PCN allergic" can safely receive cephalosporins
- Practice antimicrobial stewardship: shortest effective course, narrowest effective spectrum
- Sources: Goldman-Cecil Medicine, Tintinalli's Emergency Medicine, Washington Manual, Harrison's Principles (2025 ed.), Red Book 2021, and current BPAC antibiotic guidelines
This is a shared conversation. Sign in to Orris to start your own chat.